Apontis Pharma AG (APPH) — Cash Flow Reinvestment Rate
Apontis Pharma AG (APPH) has a Cash Flow Reinvestment Rate of 0.01x as of December 2024, reinvesting €5.60K (capex €5.60K ) from operating cash flow of €905.24K. Check Apontis Pharma AG (APPH) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Apontis Pharma AG Cash Flow Reinvestment Rate (2020–2022)
Historical reinvestment intensity for Apontis Pharma AG across 3 annual periods. Explore Apontis Pharma AG cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Apontis Pharma AG (2020–2022)
Year-by-year capital reinvestment analysis for Apontis Pharma AG. For live market cap and broader valuation context, see APPH stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.54x | €5.96 Million | €11.02 Million | €3.28 Million | ▼ -45.9% |
| 2021 | 1.00x | €3.43 Million | €3.43 Million | €1.66 Million | ▼ -3.7% |
| 2020 | 1.04x | €1.51 Million | €1.45 Million | €729.56K | — |